Amedeo Smart

Free Medical Literature Service

 

Amedeo

Dermatology
  Free Subscription

Articles published in
N Engl J Med
    June 2023
  1. TURNER NC, Oliveira M, Howell SJ, Dalenc F, et al
    Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
    N Engl J Med. 2023;388:2058-2070.
    >> Share

    May 2023
  2. GOLDBERGER T, Armoni-Weiss G
    Miliaria Crystallina.
    N Engl J Med. 2023;388:e68.
    >> Share

  3. WEN L, Cai L
    Primary Diffuse Meningeal Melanomatosis.
    N Engl J Med. 2023;388:1892.
    >> Share

  4. BARSHAK MB, Dugdale CM, Pineda R
    Case 14-2023: A 31-Year-Old Man with Redness of the Right Eye.
    N Engl J Med. 2023;388:1800-1810.
    >> Share

  5. KOTHARI R, Khare S
    Dietary Zinc Deficiency-Associated Dermatitis in a Child.
    N Engl J Med. 2023;388:1799.
    >> Share

  6. GIORDANO SH
    POSITIVE Results for Breast Cancer Survivors Who Desire Pregnancy.
    N Engl J Med. 2023;388:1709-1710.
    >> Share

  7. PARTRIDGE AH, Niman SM, Ruggeri M, Peccatori FA, et al
    Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
    N Engl J Med. 2023;388:1645-1656.
    >> Share

    April 2023
  8. NAJJAR SN, Rezigh AB
    Dissecting Cellulitis of the Scalp.
    N Engl J Med. 2023;388:1608.
    >> Share

  9. BALWANI M, Bonkovsky HL, Levy C, Anderson KE, et al
    Dersimelagon in Erythropoietic Protoporphyrias.
    N Engl J Med. 2023;388:1376-1385.
    >> Share

  10. CONNOLLY CM, Christopher-Stine L
    Periorbital Edema in Dermatomyositis.
    N Engl J Med. 2023;388:e52.
    >> Share

  11. KATZ K
    Palmar Erythema of Pregnancy.
    N Engl J Med. 2023;388:e50.
    >> Share

    March 2023
  12. MANTECON L, Solis G
    Neonatal Herpes Simplex Virus Infection.
    N Engl J Med. 2023;388:1209.
    >> Share

  13. SHISHEHBOR MH, Powell RJ, Montero-Baker MF, Dua A, et al
    Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia.
    N Engl J Med. 2023;388:1171-1180.
    >> Share

  14. TEKCAN SANLI DE, Kiziltas S
    Gastrointestinal Kaposi's Sarcoma.
    N Engl J Med. 2023;388:e45.
    >> Share

  15. AKHAM R, Hazarika N
    Paget's Disease of the Breast.
    N Engl J Med. 2023;388:1126.
    >> Share

  16. FREY SE, Goll JB, Beigel JH
    Erythema and Induration after Mpox (JYNNEOS) Vaccination Revisited.
    N Engl J Med. 2023 Mar 22. doi: 10.1056/NEJMc2215846.
    >> Share

  17. WANG HJ, Hu SC
    Malignant Acanthosis Nigricans.
    N Engl J Med. 2023;388:1031.
    >> Share

  18. SILVERBERG JI, Guttman-Yassky E, Thaci D, Irvine AD, et al
    Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
    N Engl J Med. 2023 Mar 15. doi: 10.1056/NEJMoa2206714.
    >> Share

  19. MANSOUR MK, King JD, Chen ST, Fishman JA, et al
    Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.
    N Engl J Med. 2023;388:926-937.
    >> Share

  20. FINAZZI A, Cosentini R
    Papulopustular Rash in Behcet's Disease.
    N Engl J Med. 2023;388:e30.
    >> Share

  21. MILLER DM, Emerick KS
    Skin-Cancer Chemoprevention in Transplant Recipients.
    N Engl J Med. 2023;388:844-846.
    >> Share

  22. CALLISON K, Pesko MF, Phillips S, Sosa JA, et al
    Cancer Screening after the Adoption of Paid-Sick-Leave Mandates.
    N Engl J Med. 2023;388:824-832.
    >> Share

  23. PATEL SP, Othus M, Chen Y, Wright GP Jr, et al
    Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
    N Engl J Med. 2023;388:813-823.
    >> Share

  24. ALLEN NC, Martin AJ, Snaidr VA, Eggins R, et al
    Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
    N Engl J Med. 2023;388:804-812.
    >> Share

  25. KUMAR M, Saifudeen AR
    Pseudoxanthoma Elasticum-like Syndrome.
    N Engl J Med. 2023;388:e26.
    >> Share

  26. ROHAAN MW, Kessels R, Haanen JBAG
    Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply.
    N Engl J Med. 2023;388:859-860.
    >> Share

  27. LIM AR, Shin SW
    Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma.
    N Engl J Med. 2023;388:859.
    >> Share

    February 2023
  28. HO AY, Bellon JR
    Overcoming Resistance - Omission of Radiotherapy for Low-Risk Breast Cancer.
    N Engl J Med. 2023;388:652-653.
    >> Share

  29. KUNKLER IH, Williams LJ, Jack WJL, Cameron DA, et al
    Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer.
    N Engl J Med. 2023;388:585-594.
    >> Share

  30. JIN J, Zhang Y
    Odontogenic Cutaneous Fistula.
    N Engl J Med. 2023;388:543.
    >> Share

  31. KIM BS, Bissonnette R, Nograles K, Munera C, et al
    Phase 2 Trial of Difelikefalin in Notalgia Paresthetica.
    N Engl J Med. 2023;388:511-517.
    >> Share

  32. DOSHI KB
    Calloused, Hyperpigmented Fingertips.
    N Engl J Med. 2023;388:e14.
    >> Share

    January 2023
  33. KAKURAI M, Oya K
    Atopic Eruption of Pregnancy.
    N Engl J Med. 2023;388:357.
    >> Share

  34. ROSMARIN D, Kornacki D, Ezzedine K
    Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. Reply.
    N Engl J Med. 2023;388:284.
    >> Share

  35. JANSSEN JC, Mulder EEAP, van der Veldt AAM
    Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
    N Engl J Med. 2023;388:283.
    >> Share

  36. TANG B, Chang X
    Condylomata Lata.
    N Engl J Med. 2023;388:e3.
    >> Share

  37. AGGARWAL R, Charles-Schoeman C, Schessl J
    Trial of Intravenous Immune Globulin in Dermatomyositis. Reply.
    N Engl J Med. 2023;388:94-95.
    >> Share

  38. WERTH VP, Fiorentino DF, Vleugels RA
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2023;388:94.
    >> Share

    December 2022
  39. MAALOUF NS, Morand M
    Serpentine Supravenous Hyperpigmentation.
    N Engl J Med. 2022;387:e67.
    >> Share

  40. PAYNE AS
    Topical Gene Therapy for Epidermolysis Bullosa.
    N Engl J Med. 2022;387:2281-2284.
    >> Share

  41. SCHAFFER DV
    The Coming of Age of Topical Gene Therapy for Dystrophic Epidermolysis Bullosa.
    N Engl J Med. 2022;387:2279-2280.
    >> Share

  42. GUIDE SV, Gonzalez ME, Bagci IS, Agostini B, et al
    Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
    N Engl J Med. 2022;387:2211-2219.
    >> Share

  43. VIEDMA-MARTINEZ M, Villegas Romero I
    Skin Necrosis after Transarterial Chemoembolization.
    N Engl J Med. 2022;387:2268.
    >> Share

  44. CHARI A, Minnema MC, Berdeja JG, Oriol A, et al
    Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma.
    N Engl J Med. 2022;387:2232-2244.
    >> Share

  45. ROHAAN MW, Borch TH, van den Berg JH, Met O, et al
    Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2022;387:2113-2125.
    >> Share

  46. LANG DM
    Chronic Urticaria. Reply.
    N Engl J Med. 2022;387:2103.
    >> Share

  47. ROLLA G
    Chronic Urticaria.
    N Engl J Med. 2022;387:2102-2103.
    >> Share

  48. WEINBERGER M
    Chronic Urticaria.
    N Engl J Med. 2022;387:2102.
    >> Share

  49. BONNIN AJ
    Chronic Urticaria.
    N Engl J Med. 2022;387:2101-2102.
    >> Share

  50. DESCAMPS V
    Chronic Urticaria.
    N Engl J Med. 2022;387:2101.
    >> Share

    November 2022
  51. ZHOU HY, Liu ZH
    Pyoderma Gangrenosum.
    N Engl J Med. 2022;387:e48.
    >> Share

    October 2022
  52. COHEN EM, Sobrin L, Figueiro Longo MG, Pier DB, et al
    Case 33-2022: An 11-Year-Old Girl with Redness of the Eyes.
    N Engl J Med. 2022;387:1598-1607.
    >> Share

  53. WERTH VP, Barbey C, Franchimont N
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus. Reply.
    N Engl J Med. 2022;387:1529.
    >> Share

  54. PSARRAS A, Vital EM
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:1528-1529.
    >> Share

  55. EIDSMO L
    New Hope for Patients with Vitiligo.
    N Engl J Med. 2022;387:1515-1516.
    >> Share

  56. DESAI AS, Dudzinski DM, Stib MT, Chen ST, et al
    Case 32-2022: A 76-Year-Old Man with Postoperative Cardiogenic Shock and Diffuse Rash.
    N Engl J Med. 2022;387:1502-1513.
    >> Share

  57. LEE JB, Schwartz Z
    Tinea Nigra.
    N Engl J Med. 2022;387:1501.
    >> Share

  58. ROSMARIN D, Passeron T, Pandya AG, Grimes P, et al
    Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
    N Engl J Med. 2022;387:1445-1455.
    >> Share

  59. CORTES J, Zhou X, Schmid P
    Pembrolizumab in Triple-Negative Breast Cancer. Reply.
    N Engl J Med. 2022;387:1436.
    >> Share

  60. ALTUNDAG K
    Pembrolizumab in Triple-Negative Breast Cancer.
    N Engl J Med. 2022;387:1435-1436.
    >> Share

  61. SUN R, Wei LJ
    Pembrolizumab in Triple-Negative Breast Cancer.
    N Engl J Med. 2022;387:1435.
    >> Share

  62. REBELLO A, Joshi P
    Giant-Cell Arteritis.
    N Engl J Med. 2022;387:e36.
    >> Share

  63. AMATO AA
    Intravenous Immune Globulin Therapy in Dermatomyositis.
    N Engl J Med. 2022;387:1320-1321.
    >> Share

  64. KHAITAN BK, Ahuja R
    Erythema Ab Igne.
    N Engl J Med. 2022;387:e33.
    >> Share

  65. AGGARWAL R, Charles-Schoeman C, Schessl J, Bata-Csorgo Z, et al
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2022;387:1264-1278.
    >> Share

    September 2022
  66. MODI S, Gambhire D, Cameron D
    Trastuzumab Deruxtecan in HER2-Low Breast Cancer. Reply.
    N Engl J Med. 2022;387:1145-1146.
    >> Share

  67. CARROLL HK, Higgins MJ, O'Reilly S
    Trastuzumab Deruxtecan in HER2-Low Breast Cancer.
    N Engl J Med. 2022;387:1144.
    >> Share

  68. SCHNOG JB, Samson MJ, Duits AJ
    Trastuzumab Deruxtecan in HER2-Low Breast Cancer.
    N Engl J Med. 2022;387:1143-1144.
    >> Share

  69. GROSS ND, Miller DM, Khushalani NI, Divi V, et al
    Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
    N Engl J Med. 2022 Sep 12. doi: 10.1056/NEJMoa2209813.
    >> Share

  70. FURIE RA, van Vollenhoven RF, Kalunian K, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
    N Engl J Med. 2022;387:894-904.
    >> Share

  71. LANG DM
    Chronic Urticaria.
    N Engl J Med. 2022;387:824-831.
    >> Share

    August 2022
  72. CHRISTIAN NT, Borges VF
    What Dobbs Means for Patients with Breast Cancer.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMp2209249.
    >> Share

  73. SOUMERAI JD
    Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal Mass. Reply.
    N Engl J Med. 2022;387:763-764.
    >> Share

  74. FAJGENBAUM DC
    Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal Mass. Reply.
    N Engl J Med. 2022;387:763.
    >> Share

  75. VAN RHEE F
    Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal Mass.
    N Engl J Med. 2022;387:762-763.
    >> Share

  76. ZOSHIMA T, Kawano M
    Tongue Telangiectasias in Systemic Sclerosis.
    N Engl J Med. 2022;387:737.
    >> Share

  77. KAHN M, Fleece M
    Rice Bodies in Tenosynovitis Due to Psoriatic Arthritis.
    N Engl J Med. 2022;387:e14.
    >> Share

  78. ZHANG W, Zhang ZL
    Lupus Pernio in Sarcoidosis.
    N Engl J Med. 2022;387:546.
    >> Share

    July 2022
  79. WERTH VP, Furie RA, Romero-Diaz J, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:321-331.
    >> Share

  80. BOYCE M, Flower C
    Tripe Palms.
    N Engl J Med. 2022;387:355.
    >> Share

  81. PIVOT X
    Pembrolizumab in the Treatment of Breast Cancer.
    N Engl J Med. 2022;387:273-274.
    >> Share

  82. CORTES J, Rugo HS, Cescon DW, Im SA, et al
    Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
    N Engl J Med. 2022;387:217-226.
    >> Share

  83. THORNHILL JP, Barkati S, Walmsley S, Rockstroh J, et al
    Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
    N Engl J Med. 2022 Jul 21. doi: 10.1056/NEJMoa2207323.
    >> Share

  84. HUNG WK, Chung WH
    Drug Reaction with Eosinophilia and Systemic Symptoms.
    N Engl J Med. 2022;387:167.
    >> Share

  85. HURVITZ SA
    DESTINY-Changing Results for Advanced Breast Cancer.
    N Engl J Med. 2022;387:75-76.
    >> Share

    June 2022
  86. JATOI I, Sung H, Jemal A
    The Emergence of the Racial Disparity in U.S. Breast-Cancer Mortality.
    N Engl J Med. 2022;386:2349-2352.
    >> Share

  87. ROKHZAN R, Meier K
    Targeted Therapy in Melanoma.
    N Engl J Med. 2022;386:e66.
    >> Share

  88. CORTES J, Im SA, Cathcart J
    Trastuzumab Deruxtecan for Breast Cancer. Reply.
    N Engl J Med. 2022;386:2347.
    >> Share

  89. ZHENG F, Du F, Yuan P
    Trastuzumab Deruxtecan for Breast Cancer.
    N Engl J Med. 2022;386:2346-2347.
    >> Share

  90. BASGOZ N, Brown CM, Smole SC, Madoff LC, et al
    Case 24-2022: A 31-Year-Old Man with Perianal and Penile Ulcers, Rectal Pain, and Rash.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMcpc2201244.
    >> Share

  91. MODI S, Jacot W, Yamashita T, Sohn J, et al
    Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
    N Engl J Med. 2022 Jun 5. doi: 10.1056/NEJMoa2203690.
    >> Share

    May 2022
  92. FAJGENBAUM DC, Goiffon RJ, Soumerai JD, Harris CK, et al
    Case 16-2022: A 55-Year-Old Man with Fevers, Night Sweats, and a Mediastinal Mass.
    N Engl J Med. 2022;386:2036-2048.
    >> Share

  93. TAWBI HA, Hodi FS, Long GV
    Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply.
    N Engl J Med. 2022;386:1860-1861.
    >> Share

  94. HINDIE E
    Nivolumab with or without Relatlimab in Untreated Advanced Melanoma.
    N Engl J Med. 2022;386:1860.
    >> Share

  95. ALHATEM A, Smith KC
    Primary Cutaneous Blastomycosis.
    N Engl J Med. 2022;386:e49.
    >> Share

  96. SCHMID P, Cortes J, Dent R
    Pembrolizumab in Early Triple-Negative Breast Cancer. Reply.
    N Engl J Med. 2022;386:1771-1772.
    >> Share

  97. GANGULY S, Gogia A
    Pembrolizumab in Early Triple-Negative Breast Cancer.
    N Engl J Med. 2022;386:1771.
    >> Share

  98. MESSENGER A, Harries M
    Baricitinib in Alopecia Areata.
    N Engl J Med. 2022;386:1751-1752.
    >> Share

  99. KING B, Ohyama M, Kwon O, Zlotogorski A, et al
    Two Phase 3 Trials of Baricitinib for Alopecia Areata.
    N Engl J Med. 2022;386:1687-1699.
    >> Share

    April 2022
  100. BRYANT-STEPHENS T
    Breaking the Skin Color Barriers for Asthma Medications - It's Not Black, Brown, or White.
    N Engl J Med. 2022;386:1574-1575.
    >> Share

    March 2022
  101. CORTES J, Kim SB, Chung WP, Im SA, et al
    Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
    N Engl J Med. 2022;386:1143-1154.
    >> Share

  102. ZHANG P, Chen L
    Melanoma of the Palpebral Conjunctiva and Eyelid.
    N Engl J Med. 2022 Mar 19. doi: 10.1056/NEJMicm2115699.
    >> Share

  103. LONGHURST HJ, Ameratunga R
    An Antisense Oligonucleotide for Hereditary Angioedema.
    N Engl J Med. 2022;386:1083-1085.
    >> Share

  104. BANERJI A, Phadke NA, Gottumukkala R, Sharma R, et al
    Case 8-2022: A 54-Year-Old Woman with Episodes of Swelling.
    N Engl J Med. 2022;386:1071-1079.
    >> Share

  105. LUEKING R, Lazarte S
    Malignant Syphilis.
    N Engl J Med. 2022;386:e26.
    >> Share

  106. FIJEN LM, Riedl MA, Bordone L, Bernstein JA, et al
    Inhibition of Prekallikrein for Hereditary Angioedema.
    N Engl J Med. 2022;386:1026-1033.
    >> Share

  107. ALAGESAN M, Chidambaram Y
    Pellagra.
    N Engl J Med. 2022;386:e24.
    >> Share

  108. HORTOBAGYI GN, Stemmer SM, Burris HA, Yap YS, et al
    Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.
    N Engl J Med. 2022;386:942-950.
    >> Share

    February 2022
  109. LEUNG TH, Cotsarelis G
    Cellular Memories - More Than Skin Deep.
    N Engl J Med. 2022;386:793-795.
    >> Share

  110. SILVERMAN RF, Shinder R
    Molluscum Contagiosum.
    N Engl J Med. 2022;386:582.
    >> Share

  111. SCHMID P, Cortes J, Dent R, Pusztai L, et al
    Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
    N Engl J Med. 2022;386:556-567.
    >> Share

  112. YOKOYAMA T
    Chronic Generalized Pruritus.
    N Engl J Med. 2022;386:e12.
    >> Share

  113. BRAGA NETO MB, Badley AD, Parikh SA, Graham RP, et al
    Calm before the Storm.
    N Engl J Med. 2022;386:479-485.
    >> Share

    January 2022
  114. GRAYSON PC, Perugino CA, Dinculescu VV, Ferry JA, et al
    Case 2-2022: A 70-Year-Old Man with a Recurrent Left Pleural Effusion.
    N Engl J Med. 2022;386:274-283.
    >> Share

  115. MAHARAJH S, Teelucksingh S
    Hyperpigmentation in Vitamin B12 Deficiency.
    N Engl J Med. 2022;386:172.
    >> Share

  116. FRAMPTON AE, Sivakumar S
    A New Combination Immunotherapy in Advanced Melanoma.
    N Engl J Med. 2022;386:91-92.
    >> Share

  117. TAWBI HA, Schadendorf D, Lipson EJ, Ascierto PA, et al
    Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
    N Engl J Med. 2022;386:24-34.
    >> Share

  118. JOHN LN, Beiras CG, Houinei W, Medappa M, et al
    Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication.
    N Engl J Med. 2022;386:47-56.
    >> Share

    December 2021
  119. SHARMA V, Kumar A
    Carcinoma en Cuirasse.
    N Engl J Med. 2021;385:2562.
    >> Share

  120. BACHELEZ H, Choon SE, Marrakchi S, Burden AD, et al
    Trial of Spesolimab for Generalized Pustular Psoriasis.
    N Engl J Med. 2021;385:2431-2440.
    >> Share

  121. KATAYAMA S, Ota M
    Minocycline-Induced Hyperpigmentation.
    N Engl J Med. 2021;385:2463.
    >> Share

  122. KALINSKY K, Barlow WE, Gralow JR, Meric-Bernstam F, et al
    21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
    N Engl J Med. 2021;385:2336-2347.
    >> Share

  123. WILLETT LL, Bromberg GK, Chung R, Leaf RK, et al
    Case 38-2021: A 76-Year-Old Woman with Abdominal Pain, Weight Loss, and Memory Impairment.
    N Engl J Med. 2021;385:2378-2388.
    >> Share

  124. DILLY B, Bomahou C
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2021;385:2377.
    >> Share

  125. MCKINLEY TD, Maroon M
    Linear Darier's Disease.
    N Engl J Med. 2021;385:e91.
    >> Share

  126. BIEBER T
    AhR Modulating Agent for the Topical Therapy of Plaque Psoriasis.
    N Engl J Med. 2021;385:2295-2296.
    >> Share

  127. LEBWOHL MG, Stein Gold L, Strober B, Papp KA, et al
    Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
    N Engl J Med. 2021;385:2219-2229.
    >> Share

  128. KUECKELHAUS M, Rothoeft T, De Rosa L, Yeni B, et al
    Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes.
    N Engl J Med. 2021;385:2264-2270.
    >> Share

  129. WALLACE ZS, Rodriguez K, Dau J, Bloch DB, et al
    Case 37-2021: A 60-Year-Old Man with Fevers, Fatigue, Arthralgias, a Mouth Ulcer, and a Rash.
    N Engl J Med. 2021;385:2282-2293.
    >> Share

  130. KALLESH A, Kumar VS
    Congenital Langerhans-Cell Histiocytosis.
    N Engl J Med. 2021;385:e86.
    >> Share

    November 2021
  131. WINSTON LG, Winkler ML, Kheterpal A, Villalba JA, et al
    Case 36-2021: A 22-Year-Old Man with Pain and Erythema of the Left Hand.
    N Engl J Med. 2021;385:2078-2086.
    >> Share

  132. WANG T, Chen JQ
    Tinea Capitis Due to Microsporum canis.
    N Engl J Med. 2021;385:2077.
    >> Share

  133. VARONI EM, Decani S
    Gingival Melanoma.
    N Engl J Med. 2021;385:e73.
    >> Share

  134. DIETZ BW, Winston LG, Koehler JE, Margaretten M, et al
    Copycat.
    N Engl J Med. 2021;385:1797-1802.
    >> Share

    October 2021
  135. ASKENASE PW
    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.
    >> Share

  136. AKINTILO L, Femia A
    Disseminated Cryptococcosis.
    N Engl J Med. 2021;385:1699.
    >> Share

  137. RAMIREZ-LLUCH M, Hernandez-Martin A
    Pearly Penile Papules.
    N Engl J Med. 2021;385:1420.
    >> Share

  138. TUTT ANJ, Garber JE, Geyer CE Jr
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply.
    N Engl J Med. 2021;385:1440.
    >> Share

  139. HOSHI A, Bando H, Sekine I
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
    N Engl J Med. 2021;385:1439-1440.
    >> Share

  140. NOZAWA K, Yoshimura A, Iwata H
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
    N Engl J Med. 2021;385:1439.
    >> Share

    September 2021
  141. LINDSAY ME, Dudzinski DM, Yoon BC, Jaff MR, et al
    Case 30-2021: A 47-Year-Old Man with Recurrent Unilateral Head and Neck Pain.
    N Engl J Med. 2021;385:1317-1325.
    >> Share

  142. BARRY D, Schmieder A
    Leukemia Cutis.
    N Engl J Med. 2021;385:1316.
    >> Share

  143. BOSE R, Ma CX
    Breast Cancer, HER2 Mutations, and Overcoming Drug Resistance.
    N Engl J Med. 2021;385:1241-1243.
    >> Share

  144. TSUI JC, Onishi S
    Symblepharon in Linear IgA Bullous Dermatosis.
    N Engl J Med. 2021;385:1219.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016